NetworkNewsBreaks – Delic Holdings Corp. (CSE: D
Post# of 135
(Total Views: 178)
Posted On: 07/21/2022 4:55:01 PM
NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Reports on First Full-Year Revenue, Issues KWC Status Update
Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released an update on its both its financial and corporate status. According to the announcement, the company released its first end-of-year earnings report in May, which showed $1.5 million annual revenue and a growth in net assets from $2.1 million in 2020 to $10 million by 2021 year end, a 500% year-over-year increase. In addition, the company’s Ketamine Wellness Centers (“KWC”) are reporting impressive growth, offering an estimated 100,000 treatments so far at its 13 operational, state-of-the-art clinics; the company most recently started offering SPRAVATO(R), the FDA-approved esketamine nasal spray, at its Houston, Las Vegas, Seattle, Minneapolis, Salt Lake City and Dallas locations, with more locations planning to offer the treatment soon. In addition, centers in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson have introduced NAD+ infusion therapy, with plans to expand that offering nationwide. Delic’s centers also partnered with the Veterans Administration in Arizona and launched the Ketamine Wellness Integrative Therapist Directory, which is designed to connect KWC patients with qualified mental health practitioners. “I’m very excited to say Delic Corp is thriving and continuing to grow as evidenced by the revenue we generated in our first full year of operation,” said Delic Holdings cofounder and CEO Matt Stang in the press release. “We have a strong team across all the businesses and I’m proud of the work we have done so far to make these life-changing therapies more affordable and accessible, while also working to change the perception of psychedelics and mental health. However, there are still too many people suffering with mental health conditions who are not aware of the help available to them right now. We will continue to find solutions to these challenges and make sure the treatments are more affordable and everyone who needs these therapies has access to them.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released an update on its both its financial and corporate status. According to the announcement, the company released its first end-of-year earnings report in May, which showed $1.5 million annual revenue and a growth in net assets from $2.1 million in 2020 to $10 million by 2021 year end, a 500% year-over-year increase. In addition, the company’s Ketamine Wellness Centers (“KWC”) are reporting impressive growth, offering an estimated 100,000 treatments so far at its 13 operational, state-of-the-art clinics; the company most recently started offering SPRAVATO(R), the FDA-approved esketamine nasal spray, at its Houston, Las Vegas, Seattle, Minneapolis, Salt Lake City and Dallas locations, with more locations planning to offer the treatment soon. In addition, centers in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson have introduced NAD+ infusion therapy, with plans to expand that offering nationwide. Delic’s centers also partnered with the Veterans Administration in Arizona and launched the Ketamine Wellness Integrative Therapist Directory, which is designed to connect KWC patients with qualified mental health practitioners. “I’m very excited to say Delic Corp is thriving and continuing to grow as evidenced by the revenue we generated in our first full year of operation,” said Delic Holdings cofounder and CEO Matt Stang in the press release. “We have a strong team across all the businesses and I’m proud of the work we have done so far to make these life-changing therapies more affordable and accessible, while also working to change the perception of psychedelics and mental health. However, there are still too many people suffering with mental health conditions who are not aware of the help available to them right now. We will continue to find solutions to these challenges and make sure the treatments are more affordable and everyone who needs these therapies has access to them.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)